NCT02608814

Brief Summary

Pleural infection is a potentially serious infection of the fluid normally found around the lung and current evidence suggests its incidence is increasing in both adult and paediatric populations. Identification of bacterial pathogens causing pleural infection is of paramount importance in the clinical care of patients are currently, only 40% of patients have a laboratory confirmed microbiological diagnosis for their pleural infection. An unclear diagnosis can be due to various reasons such as a small sample volume therefore the aim of the AUDIO study is to ascertain the capacity of pleural biopsies in improving the microbiological yield of pleural infection. Currently, there are no well validated methods for identifying patients presenting with pleural infection on the basis of initial ultrasound imaging. The AUDIO study will define the role of baseline thoracic ultrasound in predicting the radiographic, clinical and surgical outcomes of patients with pleural infection. The AUDIO study aims to recruit 50 patients from 2 centres with specific pleural expertise and these patients will be followed up over a 12 month period. Investigators hope that through the information gathered from ultrasound imaging and pleural biopsies, it will aid physicians' clinical and therapeutic decision making when treating patients with pleural infection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2017

Completed
Last Updated

May 16, 2017

Status Verified

May 1, 2017

Enrollment Period

1.9 years

First QC Date

October 21, 2015

Last Update Submit

May 15, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • To increase microbiological yield.

    Positive microbiological results on pleural biopsy at baseline compared with positive microbiological results on pleural fluid.

Secondary Outcomes (5)

  • Radiographic improvement in area of pleural collection measured by the percentage of the ipsilateral hemithorax occupied by effusion on chest radiography.

    Day 1 and Day 7

  • Mortality from pleural infection

    3 and 12 months

  • Duration of hospital (in patient) stay

    From the date of initial hospital admission to the date of discharge assessed up to 2 weeks.

  • Necessity for surgical fluid drainage documented in case report forms over study completion

    3 and 12 months

  • Pleural fluid drainage over 7 days

    First 7 days of trial involvement

Interventions

6 - 8 pleural biopsy samples will be taken before the insertion of the chest drain. These samples will be sent to microbiology for examination.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A clinical presentation compatible with pleural infection
  • A pleural fluid collection that may or (rarely according to clinical judgement) may not require drainage that meets at least one or more of the following criteria:
  • Purulent
  • Gram stain positive for bacteria
  • Bacterial culture positive
  • Acidic with a pH \<7.2
  • Low pleural fluid glucose \<3mmol/L (\<55mg/dL)
  • CT evidence of pleural infection (consolidation of underlying lung with enhancing pleural collection on contrast-enhanced CT)

You may not qualify if:

  • Age \<18 years
  • No pleural fluid available for analysis
  • Previous pneumonectomy on the side of pleural infection
  • Expected survival \<3 months due to co-morbid disease
  • Inability to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

North Bristol NHS Trust, Southmead Hospital

Bristol, BS10 5NB, United Kingdom

Location

Oxford Respiratory Trials Unit, Churchill Hospital

Oxford, OX3 7LE, United Kingdom

Location

MeSH Terms

Interventions

High-Energy Shock Waves

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2015

First Posted

November 20, 2015

Study Start

May 1, 2015

Primary Completion

March 14, 2017

Study Completion

March 14, 2017

Last Updated

May 16, 2017

Record last verified: 2017-05

Locations